Reduction of ventricular hypertrophy and fibrosis in spontaneously hypertensive rats by L-arginine

Chinese Journal of Physiology

Volumn 48, Issue 1, 2005, Pages 15-22

  Chang, Huai Ren ^a   Wu, Chia Yen ^a   Shu, Yung Hsiang ^a   Chen, Hsing I ^a  

^a TZU CHI UNIVERSITY   (Taiwan)

Author keywords

Cardiomyocytes; Cyclic GMP; Fibrosis; L arginin; Nitric oxide; Ventricular hypertrophy

Indexed keywords

ARGININE; COLLAGEN; CYCLIC GMP; NITRATE; NITRITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BODY WEIGHT; CONTROLLED STUDY; DRUG MECHANISM; ESSENTIAL HYPERTENSION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART RATE; HISTOPATHOLOGY; ISOLATED ARTERY; ISOMETRICS; MALE; NONHUMAN; ORGAN WEIGHT; RAT; SIGNAL TRANSDUCTION; SPONTANEOUSLY HYPERTENSIVE RAT; STRAIN DIFFERENCE; THORACIC AORTA; TREATMENT OUTCOME; VASCULAR RING;

EID: 15944382684     PISSN: 03044920     EISSN: 26660059     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Arnal, J.F., el Amrani, A.I., Chatellier, G., Menard, J. and Michel, J.B. Cardiac weight in hypertension induced by nitric oxide synthase blockade. Hypertension 22: 380-387, 1993.
2. Chang, H.-R., Lee, R.P., Wu, C.Y. and Chen, H.I. Nitric oxide in mesenteric vascular reactivity: a comparison between rats with normotension and hypertension. Clin. Exp. Pharmacol. Physiol. 29: 275-280, 2002.
3. Chang, H.-R., Wu, C.Y. and Chen, H.I. Arterial pressure following chronic blockade of endogenous nitric oxide in normotensive and hypertensive rats. Tzu Chi Med. J. 11: 41-50, 1999 (in Chinese, English abstract).
4. Chen, H.I. and Hu, C.T. Endogenous nitric oxide on arterial hemodynamics: a comparison between normotensive and hypertensive rats. Am. J. Physiol. 273: H1816-H1823, 1997.
5. Chen, P.Y. and Sanders, P.W. L-Arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J. Clin. Invest. 88: 1559-1567, 1991.
6. Dickhout, J.G. and Lee, R.M. Blood pressure and heart rate development in young spontaneously hypertensive rats. Am. J. Physiol. 274: H794-H800, 1998.
7. Dinerman, J.L., Lowenstein, C.J. and Snyder, S.H. Molecular mechanisms of nitric oxide regulation: potential relevance to cardiovascular disease. Circ. Res. 73: 217-222, 1993.
8. Fagan, J.M., Rex, S.E., Hayes-Licitra, S.A. and Waxman, L. L-Arginine reduces right heart hypertrophy in hypoxia-induced pulmonary hypertension. Biochem. Bioph. Res. Comm. 254: 100-103, 1999.
9. Frohlich, E.D. Overview of hemodynamic and non-hemodynamic factors associated with left ventricular hypertrophy. J. Mol. Cell Cardiol. 21 (suppl V): 3-10, 1989.
10. Green, L., Wagner, D., Glogowski, J., Skipper, P., Wishnok, J. and Tannenbaum, S. Analysis of nitrate, nitrite and [15N]nitrite in biological fluids. Anal. Biochem. 126: 131-138, 1982.
11. Grieve, D.J., MacCarthy, P.A., Gall, N.P., Cave, A.C. and Shah, A.M. Divergent biological actions of coronary endothelial nitric oxide during progression of cardiac hypertrophy. Hypertension 38: 267-273, 2001.
12. Hishikawa, K., Nakaki, T., Suzuki, H., Kato, R. and Saruta, T. L-Arginine as an antihypertensive agent. J. Cardiovasc. Pharmacol. 20: S196-S197, 1992.
13. Hsieh, N.K., Wang, J.Y., Liu, J.C., Wang, S.D. and Chen, H.I. Nitric oxide inhibition accelerates hypertension and induces perivascular inflammation in rats. Clin. Exp. Pharmacol. Physiol. 31: 212-218, 2004.
14. Hsieh, N.K., Wang, J.Y., Liu, J.C., Lee, W.H. and Chen, H.I. Structural changes in cerebral arteries following nitric oxide deprivation: a comparison between normotensive and hypertensive rats. Thromb. Haemost. 92: 162-170, 2004.
15. Hu, C.T., Chang, K.C., Kuo, T.S. and Chen, H.I. The correlation of cardiac mass with arterial haemodynamics of resistive and capacitive load in rats with normotension and established hypertension. Pflugers Arch. 428: 533-541, 1994.
16. Hu, C.T., Chang, K.C., Wu, C.Y. and Chen, H.I. Acute effects of nitric oxide blockade with L-NAME on arterial hemodynamics in the rat. Br. J. Pharmacol. 122: 1237-1242, 1997.
17. Kolpakov, V., Gordon, D. and Kulik, T.J. Nitric oxide-generating compounds inhibit total protein and collagen synthesis in cultured vascular smooth muscle cells. Circ. Res. 76: 305-309, 1995.
18. Kristek, F. Long-term administration of L-arginine did not influence blood pressure, heart rate, cardiac hypertrophy or arterial wall thickness of spontaneously hypertensive rats. Exp. Physiol. 83: 595-603, 1998.
19. Kuo, J.F., Davis, C.W. and Tse, J. Depressed cardiac cyclic GMP-dependent protein kinase in spontaneously hypertensive rats and its further depression by guanethidine. Nature 261: 335-336, 1976.
20. Li, H. and Forstermann, U. Nitric oxide in the pathogenesis of vascular disease. J. Pathol. 190: 244-254, 2000,
21. Lincoln, T.M., Komalavilas, P. and Cornwell, T.L. Pleiotropic regulation of vascular smooth muscle tone by cyclic GMP-dependent protein kinase. Hypertension 23 (part II): 1141-1147, 1994.
22. Masters, B.S. Structural variations to accommodate functional themes of the isoforms of NO synthases. In: Nitric Oxide, Biology and Pathobiology, edited by Ignarro, LJ: San Diego, Academic Press, 2000, pp. 91-104.
23. Matsuoka, H., Nakata, M., Kohno, K., Koga, Y., Nomura, G., Toshima H. and Imaizumi, T. Chronic L-arginine administration attenuates cardiac hypertrophy in spontaneously hypertensive rats. Hypertension 27: 14-18, 1996.
24. Moncada, S. and Higgs, A. The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329: 2002-2012, 1993.
25. Moncada, S., Radomski, M.W. and Palmer, R.M.J. Endothelium-derived relaxing factor: identification as nitric oxide and role in the control of vascular tone and platelet function. Biochem. Pharmacol. 37: 2495-2501, 1988.
26. Morgan, H.E. and Baker, K.M. Cardiac hypertrophy: mechanical, neural and endocrine dependence. Circulation 83: 13-25, 1991.
27. Nakaki, T., Hishikawa, K., Suzuki, H., Saruta, T. and Kato, R. L-Arginine-induced hypotension. Lancet 336: 696, 1990.
28. Numaguchi, K., Egashira, K., Takemoto, M., Kadokami, T., Shimokawa, H., Sueishi, K, and Takeshita A. Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats. Hypertension 26 (part I): 957-62, 1995.
29. Palmer, R.M., Ashton, D.S. and Moncada, S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333: 664-666, 1988.
30. Rossi, M.A., Ramos, S.G. and Prado, C.M. Chronic inhibition of nitric oxide synthase induces hypertension and cardiomyocyte mitochondrial and myocardial collagen remodeling in the absence of hypertrophy. J. Hypertens. 21: 993-1001, 2003.
31. Schmidt, H.H., Nau, H., Wittfoht, W., Gerlach J., Prescher, K.E., Klein, M.M., Niroomand, F. and Bohme, E. Arginine is a physiological precursor of endothelium-derived nitric oxide. Eur. J. Pharmacol. 154: 213-216, 1988.
32. 2+ -indepdent nitric oxide synthase in the myocardium. Br. J. Pharmacol. 105: 575-580, 1992.
33. Sladek, T., Gerova, M., Znojil, V. and Devat, L. Morphometric characteristics of cardiac hypertrophy induced by long-term inhibition of NO synthase. Physiol. Res. 45: 335-338, 1996.
34. Stier, C.T. Jr, Sim, G.J. and Levine, S. Dietary arginine fails to protect against cerebrovascular damage in stroke-prone hypertensive rats. Brain Res. 549: 354-356, 1991.
35. Susic, D., Francischetti, A. and Frohlich, E.D. Prolonged L-arginine on cardiovascular mass and myocardial hemodynamics and collagen in aged spontaneously hypertensive rats and normal rats. Hypertension 33 (part II): 451-455, 1999.
36. Tobian, L. and Hanlon, S. High sodium chloride diets injury arteries and raise mortality without changing blood pressure. Hypertension 15: 900-903, 1990.
37. Ursell, P.C. and Mayes, M. Anatomic distribution of nitric oxide synthase in the heart. Int. J. Cardiol. 50: 217-223, 1995.
38. Yu, H.C., Burrell, L.M., Black, M.J., Wu, L.L., Dilley, R.J., Cooper, M.E. and Johnston, C.I. Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats. Circulation 98: 2621-2628, 1998.